Skip to Content

Heart Transplant Outcomes Vary by State

WEDNESDAY, Dec. 16, 2020 -- There is significant state-level variation for outcomes among patients listed for heart transplantation in the United States, according to a study published online Dec. 9 in JAMA Network Open.

Emmanuel Akintoye, M.D., from the University of Iowa Hospitals and Clinics in Iowa City, and colleagues evaluated state-level variation in outcomes of 15,036 adult patients listed for heart transplantation (status 1A) identified from the United Network for Organ Sharing database (2011 through 2016).

The researchers found that 14.3 percent of patients died while on the waitlist, and 73 percent received transplants. The median time on the waitlist for those who received transplants was 31 days. The range for waitlist mortality was 1.0 to 7.8 deaths per 1,000 waitlist person-days, 5.6 to 34.5 transplants per 1,000 waitlist person-days for transplant rate, and 87 to 92 percent for risk-adjusted one-year graft survival. There was significant state-level variation noted when comparing the highest and lowest quartiles for waitlist mortality (hazard ratio, 1.53), transplant rate (hazard ratio, 1.57), and one-year graft survival (odds ratio, 2.07).

"Identifying and addressing the factors associated with these geographic variations in outcomes is important to ensure a fair allocation system," the authors write.

Abstract/Full Text


© 2021 HealthDay. All rights reserved.

Posted: December 2020

Read this next

Virtual Kidney Transplant Evaluation Possible

FRIDAY, Jan. 8, 2021 -- Adoption of a virtual platform has allowed continued maintenance of a large kidney transplant program despite the inability to have in-person visits during...

Odds of Anxiety, Depression, ADHD Up With Congenital Heart Disease

MONDAY, Jan. 4, 2021 -- Youth with congenital heart disease (CHD) have increased odds of anxiety and/or depression or attention-deficit/hyperactivity disorder (ADHD), regardless...

Donor Kidney Biopsies Do Not Aid Transplant Outcome Prediction

WEDNESDAY, Dec. 30, 2020 -- Use of kidney biopsy results from deceased donor kidneys does not improve prediction of allograft survival, according to a study published online Dec....

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.